Embryonic Stem Cell Lines Derived from Human Blastocysts

American Association for the Advancement of Science (AAAS) - Tập 282 Số 5391 - Trang 1145-1147 - 1998
James A. Thomson1, Joseph Itskovitz‐Eldor1, Stuart Shapiro1, Michelle Waknitz1, Jennifer J. Swiergiel1, Vivienne S. Marshall1, Jeffrey M. Jones1
1J. A. Thomson, M. A. Waknitz, J. J. Swiergiel, V. S. Marshall, Wisconsin Regional Primate Research Center, University of Wisconsin, Madison, WI 53715, USA. J. Itskovitz-Eldor, Department of Obstetrics and Gynecology, Rambam Medical Center, Faculty of Medicine, Technion, Haifa 31096, Israel. S. S. Shapiro and J. M. Jones, Department of Obstetrics and Gynecology, University of Wisconsin, Madison, WI 53715, USA.

Tóm tắt

Human blastocyst-derived, pluripotent cell lines are described that have normal karyotypes, express high levels of telomerase activity, and express cell surface markers that characterize primate embryonic stem cells but do not characterize other early lineages. After undifferentiated proliferation in vitro for 4 to 5 months, these cells still maintained the developmental potential to form trophoblast and derivatives of all three embryonic germ layers, including gut epithelium (endoderm); cartilage, bone, smooth muscle, and striated muscle (mesoderm); and neural epithelium, embryonic ganglia, and stratified squamous epithelium (ectoderm). These cell lines should be useful in human developmental biology, drug discovery, and transplantation medicine.

Từ khóa


Tài liệu tham khảo

10.1038/292154a0

10.1073/pnas.78.12.7634

10.1038/309255a0

Thomson J. A., Marshall V. S., Curr. Top. Dev. Biol. 38, 133 (1998).

Thomson J. A., et al., Proc. Natl. Acad. Sci. U.S.A. 92, 7844 (1995).

Thirty-six fresh or frozen-thawed donated human embryos produced by IVF were cultured to the blastocyst stage in G1.2 and G2.2 medium (25). Fourteen of the 20 blastocysts that developed were selected for ES cell isolation as described for rhesus monkey ES cells (5). The inner cell masses were isolated by immunosurgery (26) with a rabbit antiserum to BeWO cells and plated on irradiated (35 grays gamma irradiation) mouse embryonic fibroblasts. Culture medium consisted of 80% Dulbecco's modified Eagle's medium (no pyruvate high glucose formulation; Gibco-BRL) supplemented with 20% fetal bovine serum (Hyclone) 1 mM glutamine 0.1 mM β-mercaptoethanol (Sigma) and 1% nonessential amino acid stock (Gibco-BRL). After 9 to 15 days inner cell mass–derived outgrowths were dissociated into clumps either by exposure to Ca 2+ /Mg 2+ -free phosphate-buffered saline with 1 mM EDTA (cell line H1) by exposure to dispase (10 mg/ml; Sigma; cell line H7) or by mechanical dissociation with a micropipette (cell lines H9 H13 and H14) and replated on irradiated mouse embryonic fibroblasts in fresh medium. Individual colonies with a uniform undifferentiated morphology were individually selected by micropipette mechanically dissociated into clumps and replated. Once established and expanded cultures were passaged by exposure to type IV collagenase (1 mg/ml; Gibco-BRL) or by selection of individual colonies by micropipette. Clump sizes of about 50 to 100 cells were optimal. Cell lines were initially karyotyped at passages 2 to 7.

10.1016/0921-8734(91)90018-7

___, Vaziri H., Counter C. M., Allsopp R. C., Exp. Gerontol. 27, 375 (1992).

10.1126/science.279.5349.349

Hayflick L., Moorhead P. S., Exp. Cell Res. 25, 581 (1961).

Allsopp R. C., et al., Proc. Natl. Acad. Sci. U.S.A. 89, 10114 (1992).

Counter C. M., et al., EMBO J. 11, 1921 (1992).

Counter C. M., Hirte H. W., Bacchetti S., Harley C. B., Proc. Natl. Acad. Sci. U.S.A. 91, 2900 (1994).

Wright W. E., Piatyszek M. A., Rainey W. E., Byrd W., Shay J. W., Dev. Genet. 18, 173 (1996).

P. W. Andrews J. Oosterhuis I. Damjanov in Teratocarcinomas and Embryonic Stem Cells: A Practical Approach E. Robertson Ed. (IRL Oxford 1987) pp. 207–248.

Alkaline phosphatase was detected with Vector Blue substrate (Vector Labs). SSEA-1 SSEA-3 SSEA-4 TRA-1-60 and TRA-1-81 were detected by immunocytochemistry with specific primary monoclonal antibodies and localized with a biotinylated secondary antibody and then an avidin or biotinylated horseradish peroxidase complex (Vectastain ABC system; Vector Laboratories) as previously described (5). The ES cell lines were at passages 8 to 12 at the time markers were analyzed.

Kannagi R., et al., EMBO J. 2, 2355 (1983).

Kannagi R., et al., J. Biol. Chem. 258, 8934 (1983).

Solter D., Knowles B. B., Proc. Natl. Acad. Sci. U.S.A. 75, 5565 (1978).

hCG and α-fetoprotein were measured by specific radioimmunoassay (double AB hCG and AFP-TC kits; Diagnostic Products Los Angeles CA). hCG assays used the World Health Organization Third International Standard 75/537. H9 cells were allowed to grow to confluence (day 0) on plates of irradiated mouse embryonic fibroblasts. Medium was replaced daily. After 2 weeks of differentiation medium in triplicate wells conditioned for 24 hours was assayed for hCG and α-fetoprotein. No hCG or α-fetoprotein was detected in unconditioned medium.

R. O'Rahilly and F. Müller Developmental Stages in Human Embryos (Carnegie Institution of Washington Washington DC 1987).

Bain G., Kitchens D., Yao M., Huettner J. E., Gottlieb D. I., Dev. Biol. 168, 342 (1995).

Wiles M. V., Keller G., Development 111, 259 (1991).

Klung M. G., Soonpaa M. H., Koh G. Y., Field L. J., J. Clin. Invest. 98, 216 (1996).

Gardner D. K., et al., Fertil. Steril. 69, 84 (1998).

Solter D., Knowles B., Proc. Natl. Acad. Sci. U.S.A. 72, 5099 (1975).

We thank the personnel of the IVF clinics at the University of Wisconsin School of Medicine and at the Rambam Medical Center for the initial culture and cryopreservation of the embryos used in this study; D. Gardner and M. Lane for the G1.2 and G2.2 media; P. Andrews for the NTERA2 cl.D1 cells and the antibodies used to examine cell surface markers; C. Harris for karyotype analysis; and Geron Corporation for the 293 and MDA cell pellets and for assistance with the telomerase TRAP assay. Supported by the University of Wisconsin (UIR grant 2060) and Geron Corporation (grant 133-BU18).